Perspectum Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
263
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$245K
- Investors
-
17
Perspectum General Information
Description
Developer of an artificial intelligence-driven imaging technology designed to improve the management of metabolic diseases and cancer. The company offers vendor-agnostic disease mapping, proprietary datasets for AI training, and quantitative reports through a software-as-a-service platform, enabling physicians to make informed clinical decisions and pharmaceutical companies to advance therapeutic development.
Contact Information
Website
www.perspectum.comCorporate Office
- Gemini One
- 5520 John Smith Drive
- Oxford OX4 2LL
- England, United Kingdom
Corporate Office
- Gemini One
- 5520 John Smith Drive
- Oxford OX4 2LL
- England, United Kingdom
Perspectum Timeline
Perspectum Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Grant | 14-Nov-2024 | $245K | Completed | Generating Revenue | ||
| 18. Accelerator/Incubator | 01-Sep-2023 | Completed | Generating Revenue | |||
| 17. Later Stage VC (Series C) | 15-Mar-2023 | Completed | Generating Revenue | |||
| 16. Later Stage VC | Completed | Generating Revenue | ||||
| 15. Later Stage VC (Series B) | 17-Mar-2020 | Completed | Generating Revenue | |||
| 14. Grant | 17-Sep-2019 | Completed | Generating Revenue | |||
| 13. Grant | 01-Jul-2019 | Completed | Generating Revenue | |||
| 12. Grant | 01-Feb-2019 | Completed | Generating Revenue | |||
| 11. Grant | 01-Jan-2019 | $153K | $26.3M | Completed | Generating Revenue | |
| 10. Later Stage VC | 14-Nov-2017 | $15.8M | $26.3M | Completed | Generating Revenue |
Perspectum Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series B | ||||||||
| Series B | ||||||||
| Ordinary | ||||||||
| A Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| A Ordinary | 114,286,793 | $0.000128 | $0.03 | $0.03 | 1x | $0.03 | 14.56% | |
| Series A | 50,222,222 | $0.000128 | $0.01 | $0.01 | 1x | $0.01 | 6.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Perspectum Comparisons
Industry
Financing
Details
Perspectum Competitors (3)
One of Perspectum’s 3 competitors is EchoSens, a Private Equity-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| EchoSens | Private Equity-Backed | Paris, France | ||||
| Advantis Medical Imaging | Venture Capital-Backed | Eindhoven, Netherlands | ||||
| Resoundant | Venture Capital-Backed | Rochester, MN |
Perspectum Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Perspectum Patents
Perspectum Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202508042-D0 | Method and system for hepatocyte ballooning detection | Pending | 23-May-2025 | ||
| GB-202502059-D0 | System and method for fat fraction measurement | Pending | 12-Feb-2025 | ||
| WO-2026172149-A2 | System and method for fat fraction measurement | Pending | 12-Feb-2025 | ||
| GB-202501719-D0 | System and method for integrated medical reporting | Pending | 06-Feb-2025 | ||
| GB-202417553-D0 | Method and system for histological characterisation of bowel disease | Inactive | 29-Nov-2024 | G06T7/0012 |
Perspectum Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Perspectum Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Grow London | Accelerator/Incubator | |||
| British Business Bank | Lender/Debt Provider | Minority | ||
| Minogue Consulting | Venture Capital | Minority | ||
| Oppenheimer Holdings | Holding Company | Minority | ||
| HealthQuest Capital | Growth/Expansion | Minority |
Perspectum FAQs
-
When was Perspectum founded?
Perspectum was founded in 2012.
-
Where is Perspectum headquartered?
Perspectum is headquartered in Oxford, United Kingdom.
-
What is the size of Perspectum?
Perspectum has 263 total employees.
-
What industry is Perspectum in?
Perspectum’s primary industry is Diagnostic Equipment.
-
Is Perspectum a private or public company?
Perspectum is a Private company.
-
What is Perspectum’s current revenue?
The current revenue for Perspectum is .
-
How much funding has Perspectum raised over time?
Perspectum has raised $147M.
-
Who are Perspectum’s investors?
Grow London, British Business Bank, Minogue Consulting, Oppenheimer Holdings, and HealthQuest Capital are 5 of 17 investors who have invested in Perspectum.
-
Who are Perspectum’s competitors?
EchoSens, Advantis Medical Imaging, and Resoundant are competitors of Perspectum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
